泾阳县高三重读正规排名鄠邑区初三复读学校专业,济源市封闭学校实力提分快,西安中考冲刺怎么办,阎良区复读民办高中多少钱,秦都区初三高考复读哪家好,碑林复读哪里有联系方式,西安封闭冲刺正规会吗

Containers of fruits being sold at Walmart in nine states were recalled due to a listeria risk.On Saturday, the Food and Drug Administration posted on its website that Country Fresh expanded its voluntary recall, which they issued on Friday, to include various containers of Freshness Guaranteed-brand cut or sliced apples, grapes, mangos, pineapples, and cantaloupe distributed by Walmart.In a recall notice published on the FDA's website, Country Fresh said the FDA's voluntary recall came after a recent inspection."The recall is a precautionary measure due to possible health risk from Listeria monocytogenes detected on equipment used in an area near where these products are packed," Country Fresh said in the recall notice.According to the notice, the product is currently sold at select Walmart stores in Arkansas, Illinois, Indiana, Kansas, Kentucky, Louisiana, Missouri, Oklahoma, and Texas.Walmart stores removed removing the recalled product from shelves and inventories immediately. Shoppers who "have any recalled product on the list should not consume it and discard it immediately," according to the notice.The notice says the "best if used by" dates are between Oct. 3 and 11.You can see the entire list of recalled items and UPC numbers by clicking here.There have been no reported illnesses from the products to date, according to the notice.The original recall was for cut watermelon shipped directly to Walmart and select RaceTrac's stores in Arkansas, Missouri, Illinois, Oklahoma, and Texas. 1523

College students rely on internships to give them hands-on experience before graduating and going into the workforce. However, this year, 22% or nearly one in four college students had their summer internships canceled because of the pandemic, according to a survey done by the National Association of Colleges and Employers.“I was supposed to work with the Indianapolis Motor Speedway this summer, working full-time for about 10 weeks,” said Purdue University junior Patrick Haimbaugh. “I was really excited about it, but it did get canceled.”Fortunately for Haimbaugh, when his internship fell through, a company called TechPoint was seeing how many students were losing internships and decided it wanted to help.“It felt like I had a second chance, like the summer wasn’t just going to be a blowout,” said Haimbaugh.“We thought you know what based on our organization, position and where we sit in the community, this is an area where we can make a difference,” said Mike Langellier, the CEO of TechPoint.TechPoint normally has a summer internship program that helps about 100 students, but in the wake of the wave of internship cancellations, it decided to create a second summer internship program for five times as many students. The new program was practically created overnight and called the SOS Challenge.“Their task is over the course of five weeks to come up with a product prototype and a go-to market strategy aimed at one of nine different challenge topics, and they are all COVID related,” said Langellier. “So, they include things like tele-health, outbreak detections, restaurants and small businesses.”TechPoint got 56 other companies and more than 250 tech professionals to commit to helping with the SOS Challenge interns. Beyond the networking and mentorships, TechPoint setup the internship to have ,000 prize for the group with the best prototype and arranged for the group to get an award from Indiana’s governor.“We are excited to be able to make a difference amidst challenging times for so many people,” said Langellier.With unemployment rates so high, college graduates are entering one of the most competitive jobs markets ever. So, any extra experience now is probably more helpful than ever.“I am so thankful for the team at TechPoint,” said Haimbaugh. “For people who lost their internship, I say keep looking because there are opportunities. They are hard and it is going to be hard to get them but keep trying.” 2457

C-SPAN has suspended its political editor Steve Scully indefinitely after he admitted to lying about having his Twitter account hacked. A week ago, when Scully was questioned about a message he had sent to former Trump aide Anthony Scaramucci seeking advice, Scully claimed that someone had gotten into his account and sent it. But he admitted this week to his bosses that he had lied, feeling the pressure of attacks from President Donald Trump. Scully was supposed to moderate the second debate between Trump and Democrat Joe Biden, which had been scheduled for Thursday but was canceled. C-SPAN said it hoped to bring Scully back after some distance from the episode.President Trump seized on Thursday's news. 721

CVS hears the Amazon footsteps -- and the pharmacy giant is wasting no time trying to get ahead of any Jeff Bezos plan to disrupt the drug store business the way that he has the rest of retail.CVS said Monday that it plans to offer next day delivery of prescription drugs nationwide in 2018. In some urban markets, CVS will even deliver on the same day.A program to deliver both medications and a select offering of other CVS products from the front of the store will begin in Manhattan on December 4.CVS CEO Larry Merlo made the announcements during the company's earnings conference call with analysts.The news comes just a few weeks after reports surfaced that Amazon had received wholesale pharmacy licenses in a dozen states.That move would potentially allow Amazon to sell prescription medications online.The speculation caused the shares of CVS and rival Walgreens to fall, as did pharmacy benefits manager company Express Scripts, a competitor of the CVS-owned PBM Caremark.The stocks of drug distributors Cardinal Health, AmerisourceBergen and McKesson all fell too.This is because investors are worried that Amazon, which is already changing the dynamics of the grocery business thanks to its acquisition of Whole Foods, may look to do the same for drug stores.But Merlo said during the call with analysts Monday that he still sees Amazon as more of a potential ally than threat."You would never close the door on any type of partnership," Merlo said, when asked by an analyst about possibly working with Amazon.Still, CVS seems to recognize that the health care landscape is changing rapidly, and it needs to adjust. There have even been recent rumors that CVS may look to buy health insurer Aetna.Aetna scrapped plans to merge with rival Humana earlier this year due to intense regulatory scrutiny. Another insurer merger proposed by Anthem and Cigna died as well.Since then, the lines between health insurers and the pharmacy giants have grown increasingly blurred and incestuous.Anthem recently started up its own PBM, called IngenioRX, and has partnered with CVS.And Walgreens has partnered with a Blue Cross-backed PBM Prime Therapeutics to form a new mail order pharmacy company.Merlo and other CVS executives did not address any of the Aetna chatter on the conference call.But if the rumors are true -- and if an Aetna deal passed antitrust scrutiny -- then CVS appears to be on its way towards building a formidable health care/retail giant that may avoid getting Amazon-ed.  2507

Congress passed a bipartisan bill to address the opioid epidemic, and this week the president signed it into law. It's one of the few things that brought Democrats and Republicans together.“Opioids is definitely an issue where there's a lot of bipartisan agreement,” says Republican strategist Brian Bartlett. “We saw the Senate pass their version 99-1. The House also overwhelmingly passed legislation back in June the first time around to address this issue.”Democratic strategist Brandon Neal agrees, saying the issue of opioids is a bipartisan issue affecting everyone.On average, a person dies from an opioid overdose every eight minutes, according to the CDC.“Right now, we're in a point in our society where every average person, everyday person, is affected by this,” Neal says. “So, one pill kills.”The impact of the problem is so big, it forced both political parties to come together to pass a bill that will boost programs to treat addictions, keep a closer eye on prescriptions and promote research to find new drugs that are not as addictive.“I think the next step is to start enacting some of the changes this legislation offered, because in a lot of ways, this was a comprehensive bill, but we need to see what's going to be most effective and what works,” Bartlett says.Just this week, there was a small glimmer of hope. Early data shows the number of overdose deaths are beginning to level off and have even slightly dropped, according to Health and Human Secretary Alex Azar.“The seemingly relentless trend of rising overdose deaths seems to be finally bending in the right direction,” Azar says. 1623